Santander UK Plc Publication of Suppl.Prospcts (9040V)
August 12 2022 - 7:27AM
UK Regulatory
TIDM88GF
RNS Number : 9040V
Santander UK Plc
12 August 2022
SANTANDER UK PLC
EUR35billion GLOBAL COVERED BOND PROGRAMME
PUBLICATION OF SUPPLEMENTARY PROSPECTUS
The following supplementary prospectus (the Supplementary
Prospectus) has been approved by the UK Financial Conduct Authority
and is available for viewing:
Supplementary Prospectus dated 12 August 2022 to the prospectus
dated 4 March 2022 as supplemented on 26 April 2022, 27 June 2022
and 28 July 2022 relating to the EUR35,000,000,000 Global Covered
Bond Programme of Santander UK plc (the Prospectus).
To view the full Supplementary Prospectus please paste the
following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/9040V_1-2022-8-12.pdf
A copy of the Supplementary Prospectus has been submitted to the
National Storage Mechanism and will shortly be available for
inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The Supplementary Prospectus will also be available for viewing
via:
https://www.santander.co.uk/about-santander/investor-relations/santander-uk-covered-bonds
For further information, please contact:
Medium Term Funding
Santander UK plc
2 Triton Square
Regent's Place
London NW1 3AN
Email: mtf@santander.co.uk
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Supplementary
Prospectus and the Prospectus may be addressed to and/or targeted
at persons who are residents of particular countries only (as
specified in the Prospectus) and is not intended for use and should
not be relied upon by any person outside these countries and/or to
whom the offer contained in the Prospectus is not addressed. Prior
to relying on the information contained in the Prospectus you must
ascertain from such Prospectus whether or not you are part of the
intended addressees of the information contained therein.
This publication of the Supplementary Prospectus does not
constitute an offer of securities for sale in the United States.
The securities described in the Prospectus have not been, and will
not be, registered under the U.S. Securities Act of 1933, as
amended (the Securities Act), or under any relevant securities laws
of any state of the United States of America, and may not be
offered or sold in the United States of America or to, or for the
benefit of, U.S. persons (as defined in Regulation S of the
Securities Act), unless the securities are registered under the
Securities Act or an exemption from the registration requirements
of the Securities Act is available.
Your right to access this service is conditional upon your
compliance with the above requirement.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PSPLLLFFLVLLBBE
(END) Dow Jones Newswires
August 12, 2022 08:27 ET (12:27 GMT)
Sant Uk 28 (LSE:88GF)
Historical Stock Chart
From Dec 2024 to Jan 2025
Sant Uk 28 (LSE:88GF)
Historical Stock Chart
From Jan 2024 to Jan 2025